Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT06628570

Screening Strategies Among High-risk Populations for Anal Cancer

Conditions: Neoplasms, HPV-Related Anal Squamous Cell Carcinoma

Sex: All
Ages: 30 Years – 80 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 500
Sponsor: Lisa Flowers

Location: University of Miami Miller School of Medicine-Sylvester Cancer Center Miami Florida

Summary

The goal of the proposed research is to 1) examine the performance of emerging screening methods for anal high-grade squamous intraepithelial lesion (aHSIL), a precancerous condition of anal cancer, among populations at high risk for anal cancer and 2) characterize DNA methylation, immunologic response, and environmental factors associated with aHSIL.

Eligibility Criteria

Inclusion Criteria: * 30-80 years of age * Individuals with chronic impaired immune status * History of lower genital tract neoplasia (LGTN), Zubrod Performance Status of 0-2 Exclusion Criteria: * Patients treated for aHSIL less than 6 months before screening * History of anal cancer and pregnant women.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06628570). StuddyBuddy aggregates publicly available trial information.